Cited by 161Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The DOI matches its Crossref record; 150 of the 151 references it cites were found in a registry or an index.

Genetics ignite focus on microglial inflammation in Alzheimer’s disease

Open access

Malik, Manasi, Parikh, Ishita, Vasquez, Jared B., Smith, Conor, Tai, Leon, Bu, Guojun, LaDu, Mary Jo, Fardo, David W., Rebeck, G. William, Estus, Steven·2015·Molecular Neurodegeneration

DOI 10.1186/s13024-015-0048-1PMC PMC4595327

Open this paper in CoChat — free account Open PDF

Abstract

In the past five years, a series of large-scale genetic studies have revealed novel risk factors for Alzheimer's disease (AD). Analyses of these risk factors have focused attention upon the role of immune processes in AD, specifically microglial function. In this review, we discuss interpretation of genetic studies. We then focus upon six genes implicated by AD genetics that impact microglial function: TREM2, CD33, CR1, ABCA7, SHIP1, and APOE. We review the literature regarding the biological functions of these six proteins and their putative role in AD pathogenesis. We then present a model for how these factors may interact to modulate microglial function in AD.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1186/s13024-015-0048-1

Cites

150 of 150 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Several interactions have been reported between the AD risk genes involved in inflammation. TREM2 signals through the ITAM of DAP12 to activate microglial phagocytosis; however, TREM2 expression has also been shown to dampen pro-inflammatory cytokine production activated by TLRs. Activated CD33 recruits SHP-1 and SHP-2 to inhibit Syk signaling; CD33 has also been shown to antagonize CD14/TLR4 signaling. Sialylated apoE, which complexes with Aβ, may serve as a CD33 ligand. ApoE appears to dampen TLR4 and TLR2 signaling and inhibit induction of pro-inflammatory cytokines. SHIP1 antagonizes PI3K action by converting PIP3 to PIP2; SHIP1 has also been shown to bind to and antagonize TREM2 /DAP12 signaling in osteoclasts. SHIP1 also complexes with CD2AP, another AD-implicated protein, to inhibit Syk ubiquitination and degradation. CR1 is a C3b/C4b receptor that promotes phagocytosis; complement components have been shown to complex with Aβ. ABCA7 has been localized to phagocytic cups and linked to Aβ clearance, although its mechanism of action is currently unknown. Proteins encoded by genes associated with AD risk by genetics are shown with solid outlines; proteins that mediate these interactions are shown with dashed outlinesCC BY · PubMed Central

Fig. 2 Microglial activation can be neuroprotective and/or neurotoxic; the actions of AD risk proteins modulate these effects. The normal actions of CD33 and SHIP1 (encoded by INPP5D) appear to antagonize both forms of microglial activation, while CR1 action appears to promote both Aβ phagocytosis and the production of neurotoxic pro-inflammatory cytokines such as TNF. TREM2 appears to promote phagocytosis while dampening pro-inflammatory cytokine production. ABCA7 helps to mediate phagocytosis. APOE2 and APOE3 are anti-inflammatory, while APOE4 promotes inflammation and neurotoxicityCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Neuroinflammation in Alzheimer's disease
Heneka, M. T., Carson, M. J., Khoury, J. E., Landreth, G. E., Brosseron, F., Feinstein, D. L., Jacobs, A. H., Wyss-Coray, T., Vitorica, J., Ransohoff, R. M., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(15)70016-5 · Cited by 6,226
The M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy
Liu, C.-C., Kanekiyo, T., Xu, H., & Bu, G. (2013) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.263 · Cited by 3,459
Self-citation
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020
Variant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Initiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Naj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901
Self-citation
Replication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E., Trikalinos, T. A., & Contopoulos‐Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,834
TREM2 Lipid Sensing Sustains the Microglial Response in an Alzheimer’s Disease Model
Wang, Y., Cella, M., Mallinson, K., Ulrich, J. D., Young, K. L., Robinette, M. L., Gilfillan, S., Krishnan, G. M., Sudhakar, S., Zinselmeyer, B. H., et al. (2015) · Cell · doi:10.1016/j.cell.2015.01.049 · Cited by 1,736
Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes
Bouchon, A., Dietrich, J., & Colonna, M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.4991 · Cited by 1,284 · cited 11×
“The R47H variant blunts the TREM2-DAP12 response to anionic lipids [29]; therefore, the mutation may reflect a stage of TREM2 function intermediate between full function and the complete loss of function that is associated with the recessive Nasu-Hakola disease.”
Influential
Untitled work
Wyss-Coray (2006) · doi:10.1038/nm1484 · Cited by 1,284
Clearance of apoptotic neurons without inflammation by microglial triggering receptor expressed on myeloid cells-2
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124
Ensembl 2015
Cunningham, F., Amode, M. R., Barrell, D., Beal, K., Billis, K., Brent, S., Carvalho-Silva, D., Clapham, P., Coates, G., Fitzgerald, S., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1010 · Cited by 1,115
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Inflammation in Alzheimer Disease--A Brief Review of the Basic Science and Clinical Literature
Wyss-Coray, T., & Rogers, J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006346 · Cited by 975
Complement activation by beta-amyloid in Alzheimer disease.
Rogers, J., Cooper, N. R., Webster, S., Schultz, J., McGeer, P. L., Styren, S. D., Civin, W. H., Brachova, L., Bradt, B., & Ward, P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10016 · Cited by 817
Role of the inositol phosphatase SHIP in negative regulation of the immune system by the receptor FeγRIIB
Ono, M., Bolland, S. M., Tempst, P., & Ravetch, J. V. (1996) · Nature · doi:10.1038/383263a0 · Cited by 773
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Cutting Edge: TREM-2 Attenuates Macrophage Activation
Turnbull, I. R., Gilfillan, S., Cella, M., Aoshi, T., Miller, M., Piccio, L., Hernandez, M., & Colonna, M. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.3520 · Cited by 688
Mutations in Two Genes Encoding Different Subunits of a Receptor Signaling Complex Result in an Identical Disease Phenotype
Paloneva, J., Manninen, T., Christman, G., Hovanes, K., Mandelin, J., Adolfsson, R., Bianchin, M., Bird, T., Miranda, R., Salmaggi, A., et al. (2002) · The American Journal of Human Genetics · doi:10.1086/342259 · Cited by 683
TREM2 deficiency eliminates TREM2+ inflammatory macrophages and ameliorates pathology in Alzheimer’s disease mouse models
Jay, T. R., Miller, C. M., Cheng, P. J., Graham, L. C., Bemiller, S., Broihier, M. L., Xu, G., Margevicius, D., Karlo, J. C., Sousa, G. L., et al. (2015) · Journal of Experimental Medicine · doi:10.1084/jem.20142322 · Cited by 682 · cited 4×
“We hypothesize that enhanced TREM2 function reduces AD risk, although as discussed above, this hypothesis is not supported by all current data [29, 57, 58].”
BackgroundResultInfluential
The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase.
Damen, J. E., Liu, L., Rosten, P., Humphries, R. K., Jefferson, A. B., Majerus, P. W., & Krystal, G. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.4.1689 · Cited by 633
CD14 and Toll-Like Receptors 2 and 4 Are Required for Fibrillar Aβ-Stimulated Microglial Activation
Reed-Geaghan, E. G., Savage, J. C., Hise, A. G., & Landreth, G. E. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3158-09.2009 · Cited by 591
CD33 Alzheimer's disease locus: altered monocyte function and amyloid biology
Initiative, T. A. D. N., Bradshaw, E. M., Chibnik, L. B., Keenan, B. T., Ottoboni, L., Raj, T., Tang, A., Rosenkrantz, L. L., Imboywa, S., Lee, M., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3435 · Cited by 570
Siglecs—the major subfamily of I-type lectins
Varki, A. P., & Angata, T. (2005) · Glycobiology · doi:10.1093/glycob/cwj008 · Cited by 527
Profile and Regulation of Apolipoprotein E (ApoE) Expression in the CNS in Mice with Targeting of Green Fluorescent Protein Gene to the ApoE Locus
Xu, Q., Bernardo, A., Walker, D., Kanegawa, T., Mahley, R. W., & Huang, Y. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5476-05.2006 · Cited by 524
Deletion of SHIP or SHP-1 Reveals Two Distinct Pathways for Inhibitory Signaling
Ono, M., Okada, H., Bolland, S. M., Yanagi, S., Kurosaki, T., & Ravetch, J. V. (1997) · Cell · doi:10.1016/s0092-8674(00)80337-2 · Cited by 490
A role for TREM2 ligands in the phagocytosis of apoptotic neuronal cells by microglia
Hsieh, C. L., Koike, M., Spusta, S. C., Niemi, E. C., Yenari, M., Nakamura, M. C., & Seaman, W. E. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06042.x · Cited by 475
Loss-of-function mutations in TYROBP (DAP12) result in a presenile dementia with bone cysts
Paloneva, J., Kestilä, M., Wu, J., Salminen, A., Böhling, T., Ruotsalainen, V., Hakola, P., Bakker, A. B. H., Phillips, J. H., Pekkarinen, P., et al. (2000) · Nature Genetics · doi:10.1038/77153 · Cited by 460
A DAP12-mediated pathway regulates expression of CC chemokine receptor 7 and maturation of human dendritic cells
Bouchon, A., Hernández-Munain, C., Cella, M., & Colonna, M. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.8.1111 · Cited by 460
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Cutting Edge: Inhibition of TLR and FcR Responses in Macrophages by Triggering Receptor Expressed on Myeloid Cells (TREM)-2 and DAP12
Hamerman, J. A., Jarjoura, J. R., Humphrey, M. B., Nakamura, M. C., Seaman, W. E., & Lanier, L. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.4.2051 · Cited by 440
Meta-analysis Confirms CR1, CLU, and PICALM as Alzheimer Disease Risk Loci and Reveals Interactions With APOE Genotypes
Jun, G. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.201 · Cited by 422
p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity.
Lioubin, M. N., Algate, P. A., Tsai, S., Carlberg, K., Aebersold, A., & Rohrschneider, L. R. (1996) · Genes & Development · doi:10.1101/gad.10.9.1084 · Cited by 418
TREM2-Transduced Myeloid Precursors Mediate Nervous Tissue Debris Clearance and Facilitate Recovery in an Animal Model of Multiple Sclerosis
Takahashi, K., Prinz, M., Stagi, M., Chechneva, O., & Neumann, H. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040124 · Cited by 414
TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1
Peng, Q., Malhotra, S., Torchia, J. A., Kerr, W. G., Coggeshall, K. M., & Humphrey, M. B. (2010) · Science Signaling · doi:10.1126/scisignal.2000500 · Cited by 413
TREM2 in neurodegeneration: evidence for association of the p.R47H variant with frontotemporal dementia and Parkinson’s disease
Rayaprolu, S., Mullen, B., Baker, M., Lynch, T., Finger, E., Seeley, W. W., Hatanpaa, K. J., Lomen-Hoerth, C., Kertesz, A., Bigio, E. H., et al. (2013) · Molecular Neurodegeneration · doi:10.1186/1750-1326-8-19 · Cited by 404
APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response
Lynch, J. R., Tang, W., Wang, H., Vitek, M. P., Bennett, E. R., Sullivan, P. M., Warner, D. S., & Laskowitz, D. T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306923200 · Cited by 394
APOE genotype-specific differences in the innate immune response
Vitek, M. P., Brown, C. M., & Colton, C. A. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.11.014 · Cited by 362
LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide
Liu, Y., Walter, S., Stagi, M., Cherny, D., Letièmbre, M., Schulz‐Schaeffer, W., Heine, H., Penke, B., Neumann, H., & Fassbender, K. C. (2005) · Brain · doi:10.1093/brain/awh531 · Cited by 349
Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease Brain
Yasojima, K., Schwab, C., McGeer, E. G., & McGeer, P. L. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65340-0 · Cited by 328
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
DemGene, Steinberg, S., Stefansson, H., Jonsson, T., Johannsdottir, H., Ingason, A., Helgason, H., Sulem, P., Magnusson, O. T., Gudjonsson, S. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3246 · Cited by 324
LXRs Regulate ER Stress and Inflammation through Dynamic Modulation of Membrane Phospholipid Composition
Rong, X., Albert, C. J., Hong, C., Duerr, M. A., Chamberlain, B. T., Tarling, E. J., Ito, A., Gao, J., Wang, B., Edwards, P. A., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.10.002 · Cited by 323
Altered microglial response to Aβ plaques in APPPS1-21 mice heterozygous for TREM2
Ulrich, J. D., Finn, M. B., Wang, Y., Shen, A., Mahan, T. E., Jiang, H., Stewart, F. R., Piccio, L., Colonna, M., & Holtzman, D. M. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-20 · Cited by 302
APOE4-specific Changes in Aβ Accumulation in a New Transgenic Mouse Model of Alzheimer Disease
Youmans, K. L., Tai, L. M., Nwabuisi-Heath, E., Jungbauer, L., Kanekiyo, T., Gan, M., Kim, J., Eimer, W. A., Estus, S., Rebeck, G. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.407957 · Cited by 268
Self-citation
CD33 Alzheimer’s risk-altering polymorphism, CD33 expression, and exon 2 splicing
Malik, M., Simpson, J. F., Parikh, I., Wilfred, B. R., Fardo, D. W., Nelson, P. T., & Estus, S. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.1224-13.2013 · Cited by 262
Self-citation
TREM2and Neurodegenerative Disease
Reitz, C., & Mayeux, R. P. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1306509 · Cited by 258
TREM2 is upregulated in amyloid plaque-associated microglia in aged APP23 transgenic mice
Frank, S., Burbach, G. J., Bonin, M., Walter, M., Streit, W., Bechmann, I., & Deller, T. (2008) · Glia · doi:10.1002/glia.20710 · Cited by 247
Interaction of SLP adaptors with the SH2 domain of Tec family kinases
Su, Y., Zhang, Y., Schweikert, J., Koretzky, G. A., Reth, M. G., & Wienands, J. (1999) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199911)29:11 · Cited by 242
Generation of membrane structures during phagocytosis and chemotaxis of macrophages: role and regulation of the actin cytoskeleton
Rougerie, P., Miskolci, V., & Cox, D. (2013) · Immunological Reviews · doi:10.1111/imr.12118 · Cited by 237
Alzheimer risk associated with a copy number variation in the complement receptor 1 increasing C3b/C4b binding sites
Brouwers, N., Van Cauwenberghe, C., Engelborghs, S., Lambert, J.-C., Bettens, K., Le Bastard, N., Pasquier, F., Montoya, A. G., Peeters, K., Mattheijssens, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.24 · Cited by 227
APOE genotype alters glial activation and loss of synaptic markers in mice
Zhu, Y., Nwabuisi‐Heath, E., Dumanis, S. B., Tai, L. M., Yu, C., Rebeck, G. W., & Ladu, M. J. (2012) · Glia · doi:10.1002/glia.22289 · Cited by 224
Self-citation
Curses—Winner's and Otherwise—in Genetic Epidemiology
Kraft, P. L. (2008) · Epidemiology · doi:10.1097/ede.0b013e318181b865 · Cited by 222
Multiple forms of an inositol polyphosphate 5-phosphatase form signaling complexes with Shc and Grb2
Kavanaugh, W. M., Pot, D. A., Chin, S. M., Deuter-Reinhard, M., Jefferson, A. B., Norris, F. A., Masiarz, F. R., Cousens, L. S., Majerus, P. W., & Williams, L. T. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00511-0 · Cited by 217
Deletion ofAbca7Increases Cerebral Amyloid-β Accumulation in the J20 Mouse Model of Alzheimer's Disease
Kim, W. S., Li, H., Ruberu, K. R., Chan, S. L., Elliott, D. A., Low, J. K., Cheng, D., Karl, T., & Garner, B. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.4165-12.2013 · Cited by 216
Complement Receptor 1: Disease associations and therapeutic implications
Khera, R., & Das, N. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.09.026 · Cited by 213
ATP-binding cassette transporter A7 enhances phagocytosis of apoptotic cells and associated ERK signaling in macrophages
Jehle, A. W., Gardai, S. J., Li, S., Linsel‐Nitschke, P., Morimoto, K., Janssen, W. J., Vandivier, R. W., Wang, N., Greenberg, S., Dale, B. M., et al. (2006) · The Journal of Cell Biology · doi:10.1083/jcb.200601030 · Cited by 213
TLR Signaling: An Emerging Bridge from Innate Immunity to Atherogenesis
Michelsen, K. S., Doherty, T. M., Shah, P. K., & Arditi, M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.10.5901 · Cited by 211
Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells
Bakker, A. B. H., Baker, E. G., Sutherland, G. R., Phillips, J. H., & Lanier, L. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.17.9792 · Cited by 210
CNS manifestations of Nasu–Hakola disease
Bm, J., Autti, T., Raininko, R., Partanen, J., Salonen, O., Puranen, M., Hakola, P., & Haltia, M. (2001) · Neurology · doi:10.1212/wnl.56.11.1552 · Cited by 205
ATP-binding Cassette Transporter A7 (ABCA7) Binds Apolipoprotein A-I and Mediates Cellular Phospholipid but Not Cholesterol Efflux
Wang, N., Lan, D., Gerbod-Giannone, M. C., Linsel‐Nitschke, P., Jehle, A. W., Chen, W., Martinez, L. O., & Tall, A. R. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307831200 · Cited by 205
Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2
Paul, S. P., Taylor, L. S., Stansbury, E. K., & McVicar, D. W. (2000) · Blood · doi:10.1182/blood.v96.2.483 · Cited by 204
APOE2 enhances neuroprotection against Alzheimer’s disease through multiple molecular mechanisms
Conejero-Goldberg, C., Gomar, J. J., Bobes-Bascaran, T., Hyde, T. M., Kleinman, J. E., Herman, M. M., Chen, S., Davies, P., & Goldberg, T. E. (2014) · Molecular Psychiatry · doi:10.1038/mp.2013.194 · Cited by 199
Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition
Rodriguez, G. A., Tai, L. M., LaDu, M. J., & Rebeck, G. W. (2014) · Journal of Neuroinflammation · doi:10.1186/1742-2094-11-111 · Cited by 193
Self-citation
Quantifying and correcting for the winner's curse in genetic association studies
Xiao, R., & Boehnke, M. (2009) · Genetic Epidemiology · doi:10.1002/gepi.20398 · Cited by 192
Human ABCA7 Supports Apolipoprotein-mediated Release of Cellular Cholesterol and Phospholipid to Generate High Density Lipoprotein
Abe-Dohmae, S., Ikeda, Y., Matsuo, M., Hayashi, M., Okuhira, K., Ueda, K., & Yokoyama, S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m309888200 · Cited by 191
Apolipoprotein E modulates glial activation and the endogenous central nervous system inflammatory response
Lynch, J., Morgan, D., Mance, J., Matthew, W. D., & Laskowitz, D. T. (2001) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00459-8 · Cited by 189
Differential regulation of BACE1 promoter activity by nuclear factor‐κB in neurons and glia upon exposure to β‐amyloid peptides
Bourne, K. Z., Ferrari, D. C., Lange‐Dohna, C., Roßner, S., Wood, T. G., & Perez-Polo, J. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21252 · Cited by 188
The Myeloid-specific Sialic Acid-binding Receptor, CD33, Associates with the Protein-tyrosine Phosphatases, SHP-1 and SHP-2
Taylor, V., Buckley, C. D., Douglas, M., Cody, A. J., Simmons, D. L., & Freeman, S. D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11505 · Cited by 186
Systemic Inflammation, Infection, ApoE Alleles, and Alzheimer Disease: A Position Paper
Finch, C. E., & Morgan, T. E. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362254 · Cited by 180
The Inositol 5′-Phosphatase SHIP Binds to Immunoreceptor Signaling Motifs and Responds to High Affinity IgE Receptor Aggregation
Osborne, M. A., Zenner, G., Lubinus, M., Zhang, X., Songyang, Z., Cantley, L. C., Majerus, P. W., Burn, P., & Kochan, J. P. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29271 · Cited by 174
Identification of a Novel Human Sterol-Sensitive ATP-Binding Cassette Transporter (ABCA7)
Kaminski, W. E., Orsó, E., Diederich, W., Klucken, J., Drobnik, W., & Schmitz, G. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2954 · Cited by 166
Specific lipid recognition is a general feature of CD300 and TREM molecules
Cannon, J. P., O’Driscoll, M., & Litman, G. W. (2011) · Immunogenetics · doi:10.1007/s00251-011-0562-4 · Cited by 165
APOE‐modulated Aβ‐induced neuroinflammation in Alzheimer's disease: current landscape, novel data, and future perspective
Tai, L. M., Ghura, S., Koster, K. P., Liakaite, V., Maienschein‐Cline, M., Kanabar, P., Collins, N., Ben‐Aissa, M., Lei, A. Z., Bahroos, N., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13072 · Cited by 165
Self-citation
Distribution and signaling of TREM2/DAP12, the receptor system mutated in human polycystic lipomembraneous osteodysplasia with sclerosing leukoencephalopathy dementia
Sessa, G., Podini, P., Mariani, M., Meroni, A., Spreafico, R., Sinigaglia, F., Colonna, M., Panina, P., & Meldolesi, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03729.x · Cited by 165
Quantitation of ATP-binding cassette subfamily-A transporter gene expression in primary human brain cells
Kim, W. S., Guillemin, G. J., Glaros, E. N., Lim, C. K., & Garner, B. (2006) · Neuroreport · doi:10.1097/01.wnr.0000221833.41340.cd · Cited by 158
A Regulatory Role for Src Homology 2 Domain–Containing Inositol 5′-Phosphatase (Ship) in Phagocytosis Mediated by Fcγ Receptors and Complement Receptor 3 (α M β 2; Cd11b/Cd18)
Cox, D., Dale, B. M., Kashiwada, M., Helgason, C. D., & Greenberg, S. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.1.61 · Cited by 158
Nuclear Receptors License Phagocytosis by Trem2+Myeloid Cells in Mouse Models of Alzheimer's Disease
Savage, J. C., Jay, T., Goduni, E., Quigley, C., Mariani, M. M., Malm, T., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4586-14.2015 · Cited by 154 · cited 1×
“While the role of TREM2 in phagocytosis may have important implications for Aβ clearance in AD [53], the R47H variant has also been implicated in Parkinson’s disease and frontotemporal dementia (FTD), neither of which centrally involves amyloid [54].”
Background
High glucose concentrations induce TNF-α production through the down-regulation of CD33 in primary human monocytes
González, Y., Herrera, M. T., Soldevila, G., García‐García, L., Fabián, G., Pérez-Armendáriz, E. M., Bobadilla, K., Guzmán‐Beltrán, S., Sada, E., & Torres, M. (2012) · BMC Immunology · doi:10.1186/1471-2172-13-19 · Cited by 149
CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer’s disease susceptibility
Raj, T., Ryan, K. J., Replogle, J. M., Chibnik, L. B., Rosenkrantz, L., Tang, A., Rothamel, K., Stranger, B. E., Bennett, D. A., Evans, D. A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt666 · Cited by 144
Constitutive repressor activity of CD33 on human monocytes requires sialic acid recognition and phosphoinositide 3‐kinase‐mediated intracellular signaling
Lajaunias, F., Dayer, J., & Chizzolini, C. (2004) · European Journal of Immunology · doi:10.1002/eji.200425273 · Cited by 143
LRP in Amyloid‐β Production and Metabolism
Bu, G., Cam, J. A., & Zerbinatti, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1377.005 · Cited by 141
Self-citation
Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism
An, H., Xu, H., Zhang, M., Zhou, J., Feng, T., Qian, C., Qi, R., & Cao, X. (2005) · Blood · doi:10.1182/blood-2005-01-0191 · Cited by 140
Dual Induction of TREM2 and Tolerance-Related Transcript, Tmem176b, in Amyloid Transgenic Mice: Implications for Vaccine-Based Therapies for Alzheimer’s Disease
Melchior, B., Garcia, A., Hsiung, B., Lo, K. M., Doose, J. M., Thrash, J. C., Stalder, A. K., Staufenbiel, M., Neumann, H., & Carson, M. J. (2010) · ASN NEURO · doi:10.1042/an20100010 · Cited by 134
A study of CD33 (SIGLEC-3) antigen expression and function on activated human T and NK cells: two isoforms of CD33 are generated by alternative splicing
Hernández‐Caselles, T., Martinez‐Esparza, M., Pérez‐Oliva, A. B., Quintanilla-Cecconi, A. M., García-Alonso, A. M., Álvarez‐López, D. M. R., & García–Peñarrubia, P. (2005) · Journal of Leukocyte Biology · doi:10.1189/jlb.0205096 · Cited by 133
CD33/Siglec-3 Binding Specificity, Expression Pattern, and Consequences of Gene Deletion in Mice
der Linden, E. C. M. B.-V., Angata, T., Reynolds, S. A., Powell, L. D., Hedrick, S. Μ., & Varki, A. P. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.12.4199-4206.2003 · Cited by 133
Inflammation, Apoptosis, and Alzheimer's Disease
Bamberger, M. E., & Landreth, G. E. (2002) · The Neuroscientist · doi:10.1177/1073858402008003013 · Cited by 129
and Alzheimer's disease
Brioni, J. D., Esbenshade, T. A., Garrison, T. R., Bitner, S. R., & Cowart, M. (2010) · Cited by 125
The three new pathways leading to Alzheimer's disease
Morgan, K. (2011) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2011.01181.x · Cited by 122
Apolipoprotein E Deficiency Worsens Outcome From Global Cerebral Ischemia in the Mouse
Sheng, H., Laskowitz, D. T., Mackensen, G. B., Kudo, M., Pearlstein, R. D., & Warner, D. S. (1999) · Stroke · doi:10.1161/01.str.30.5.1118 · Cited by 118
Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia
Ruiz, A., Dols-Icardo, O., Bullido, M. J., Pastor, P., Rodríguez-Rodríguez, E., López de Munain, A., de Pancorbo, M. M., Pérez-Tur, J., Álvarez, V., Antonell, A., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.08.011 · Cited by 118
Microglial activatory (immunoreceptor tyrosine‐based activation motif)‐ and inhibitory (immunoreceptor tyrosine‐based inhibition motif)‐signaling receptors for recognition of the neuronal glycocalyx
Linnartz‐Gerlach, B., & Neumann, H. (2012) · Glia · doi:10.1002/glia.22359 · Cited by 117
Evidence for normal aging of the septo-hippocampal cholinergic system in apoE (−/−) mice but impaired clearance of axonal degeneration products following injury
Fagan, A. M., Murphy, B. A., Patel, S. N., Kilbridge, J. F., Mobley, W. C., Bu, G., & Holtzman, D. M. (1998) · Experimental Neurology · doi:10.1006/exnr.1998.6818 · Cited by 116
Self-citation
Evidence of the association of BIN1 and PICALM with the AD risk in contrasting European populations
Lambert, J., Zélénika, D., Hiltunen, M., Chouraki, V. A., Combarros, O., Bullido, M. J., Tognoni, G., Fiévet, N., Boland, A., Arosio, B., et al. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.11.022 · Cited by 111
Apolipoprotein E affects the central nervous system response to injury and the development of cerebral edema
Lynch, J. R., Pineda, J. A., Morgan, D., Zhang, L., Warner, D. S., Benveniste, H., & Laskowitz, D. T. (2002) · Annals of Neurology · doi:10.1002/ana.10098 · Cited by 111
Effects of apoE genotype on macrophage inflammation and heme oxygenase-1 expression
Jofre‐Monseny, L., Łoboda, A., Wagner, A. E., Huebbe, P., Boesch, C., Józkowicz, A., Minihane, A. M., Dulak, J., & Rimbach, G. H. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.150 · Cited by 108
Heterogeneity of presenile dementia with bone cysts (Nasu–Hakola disease)
Kondo, T., Takahashi, K., Kohara, N., Takahashi, Y., Hayashi, S., Takahashi, H., Matsuo, H., Yamazaki, M., Inoue, K., Miyamoto, K., et al. (2002) · Neurology · doi:10.1212/wnl.59.7.1105 · Cited by 106
The effect of phosphatases SHP-1 and SHIP-1 on signaling by the ITIM- and ITAM-containing Fcγ receptors FcγRIIB and FcγRIIA
Huang, Z.-Y., Hunter, S., Kim, M.-K., Indik, Z. K., & Schreiber, A. D. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0902454 · Cited by 105
Neuroinflammation in the Aging Down Syndrome Brain; Lessons from Alzheimer's Disease
Wilcock, D. M. (2012) · Current Gerontology and Geriatrics Research · doi:10.1155/2012/170276 · Cited by 104
ABCA7 expression is associated with Alzheimer's disease polymorphism and disease status
Vasquez, J. B., Fardo, D. W., & Estus, S. (2013) · Neuroscience Letters · doi:10.1016/j.neulet.2013.09.058 · Cited by 101
Self-citation
Blockage of CR1 prevents activation of rodent microglia
Crehan, H., Hardy, J., & Pocock, J. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.02.003 · Cited by 98
A coding variant in CR1 interacts with APOE-ɛ4 to influence cognitive decline
Keenan, B. T., Shulman, J. M., Chibnik, L. B., Raj, T., Tran, D., Sabuncu, M. R., Initiative, T. A. D. N., Allen, A. N., Corneveaux, J. J., Hardy, J., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds054 · Cited by 97
Low‐density lipoprotein receptors regulate microglial inflammation through c‐Jun N‐terminal kinase
Pocivavsek, A., Burns, M. P., & Rebeck, G. W. (2009) · Glia · doi:10.1002/glia.20772 · Cited by 96
Self-citation
Feedback regulation of lymphocyte signalling
Reth, M. G., & Brummer, T. (2004) · Nature reviews. Immunology · doi:10.1038/nri1335 · Cited by 92
Erythropoietin and Interleukin-3 Activate Tyrosine Phosphorylation of CBL and Association With CRK Adaptor Proteins
Barber, D. L., Mason, J. M., Fukazawa, T., Reedquist, K. A., Druker, B. J., Band, H., & D’Andrea, A. D. (1997) · Blood · doi:10.1182/blood.v89.9.3166 · Cited by 92
Traumatic Brain Injury Exacerbates Neurodegenerative Pathology: Improvement with an Apolipoprotein E-Based Therapeutic
Laskowitz, D. T., Song, P., Wang, H., Mace, B. E., Sullivan, P. M., Vitek, M. P., & Dawson, H. N. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2010.1396 · Cited by 91
Microglial Immunoreceptor Tyrosine-Based Activation and Inhibition Motif Signaling in Neuroinflammation
Linnartz, B., Wang, Y., & Neumann, H. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/587463 · Cited by 87
Genetic association of CR1 with Alzheimer's disease: A tentative disease mechanism
Hazrati, L., Cauwenberghe, C. V., Brooks, P. L., Brouwers, N., Ghani, M., Sato, C., Cruts, M., Sleegers, K., George‐Hyslop, P. S., Broeckhoven, C. V., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.07.001 · Cited by 86
An Apolipoprotein E-Mimetic Stimulates Axonal Regeneration and Remyelination after Peripheral Nerve Injury
Li, F., Fowler, K. A., Neil, J. E., Colton, C. A., & Vitek, M. P. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.167882 · Cited by 85
Endogenous apolipoprotein E suppresses LPS-stimulated microglial nitric oxide production
Laskowitz, D. T., Matthew, W. D., Bennett, E. R., Schmechel, D. E., Herbstreith, M. H., Goel, S., & McMillian, M. (1998) · Neuroreport · doi:10.1097/00001756-199803090-00010 · Cited by 84
Genetics of CD33 in Alzheimer's disease and acute myeloid leukemia
Malik, M., Chiles, J. W., Xi, H. S., Medway, C., Simpson, J. F., Potluri, S., Howard, D. S., Yu, L., Paumi, C. M., Mukherjee, S., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv092 · Cited by 84
Self-citation
ITIM-dependent endocytosis of CD33-related Siglecs: role of intracellular domain, tyrosine phosphorylation, and the tyrosine phosphatases, Shp1 and Shp2
Walter, R. B., Raden, B. W., Zeng, R., Häusermann, P., Bernstein, I. D., & Cooper, J. A. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0607388 · Cited by 80
Differential Association of Phosphatidylinositol 3-Kinase, SHIP-1, and PTEN with Forming Phagosomes
Kamen, L. A., Levinsohn, J. L., & Swanson, J. A. (2007) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-01-0061 · Cited by 79
Implication of Complement System and its Regulators in Alzheimers Disease
Kolev, M. V., Ruseva, M. M., Harris, C. L., Morgan, B. P., & Donev, R. (2009) · Current Neuropharmacology · doi:10.2174/157015909787602805 · Cited by 78
Epitope mapping, expression and post-translational modifications of two isoforms of CD33 (CD33M and CD33m) on lymphoid and myeloid human cells
Pérez‐Oliva, A. B., Martinez‐Esparza, M., Vicente-Fernandez, J. J., Corral-San-Miguel, R., García–Peñarrubia, P., & Hernández‐Caselles, T. (2011) · Glycobiology · doi:10.1093/glycob/cwq220 · Cited by 77
Siglec receptors and hiding plaques in Alzheimer's disease
Salminen, A., & Kaarniranta, K. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0472-1 · Cited by 73
Posttranscriptional regulation of human ABCA7 and its function for the apoA-I-dependent lipid release
Ikeda, Y., Abe-Dohmae, S., Munehira, Y., Aoki, R., Kawamoto, S., Furuya, A., Shitara, K., Amachi, T., Kioka, N., Matsuo, M., et al. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.10.002 · Cited by 72
TREM2 and Parkinson’s Disease
Benítez, B. A., & Cruchaga, C. (2013) · PubMed Central · doi:10.1056/nejmc1306509#sa4 · Cited by 64
Microglial low-density lipoprotein receptor-related protein 1 modulates c-Jun N-terminal kinase activation
Pocivavsek, A., MIKHAILENKO, I. A., Strickland, D. K., & Rebeck, G. W. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.010 · Cited by 63
Self-citation
Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family
Numasawa, Y., Yamaura, C., Ishihara, S., Shintani, S., Yamazaki, M., Tabunoki, H., & Satoh, J. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03311.x · Cited by 58
Amyloid beta-protein and lipid metabolism
Zinser, E. G., Hartmann, T., & Grimm, M. O. W. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.02.014 · Cited by 55
Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice
Goldklang, M. P., Golovatch, P., Zelonina, T., Trischler, J., Rabinowitz, D., Lemaître, V., & D'Armiento, J. M. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00454.2010 · Cited by 54
The SH2-Containing 5′-Inositol Phosphatase (SHIP) Is Tyrosine Phosphorylated after Fcγ Receptor Clustering in Monocytes
Maresco-Pennisi, D. L., Osborne, J. M., Cooney, D. S., Coggeshall, K. M., & Anderson, C. L. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6458 · Cited by 53
The SH2-containing 5'-inositol phosphatase (SHIP) is tyrosine phosphorylated after Fc gamma receptor clustering in monocytes.
Maresco-Pennisi, D. L., Osborne, J. M., Cooney, D. S., Coggeshall, K. M., & Anderson, C. L. (1999) · PubMed · Cited by 52
Apolipoprotein E Plays a Key Role against Cryptosporidial Infection in Transgenic Undernourished Mice
de Azevedo, O. G. R., Bolick, D. T., Roche, J. K., Pinkerton, R., Lima, A. Â. M., Vitek, M. P., Warren, C. A., Oriá, R. B., & Guerrant, R. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0089562 · Cited by 51
The SH2 Inositol 5-Phosphatase Ship1 Is Recruited in an SH2-dependent Manner to the Erythropoietin Receptor
Mason, J. M., Beattie, B. K., Liu, Q., Dumont, D., & Barber, D. L. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4398 · Cited by 50
Negative Regulation of Toll-like Receptor-4 Signaling through the Binding of Glycosylphosphatidylinositol-anchored Glycoprotein, CD14, with the Sialic Acid-binding Lectin, CD33
Ishida, A., Akita, K., Mori, Y., Tanida, S., Toda, M., Inoue, M., & Nakada, H. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.523480 · Cited by 49
Sialylated Human Apolipoprotein E (apoEs) Is Preferentially Associated with Neuron-Enriched Cultures from APOE Transgenic Mice
Xu, P., Schmechel, D. E., Qiu, H.-L., Herbstreith, M. H., Rothrock‐Christian, T., Eyster, M. V., Roses, A. D., & Gilbert, J. R. (1999) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0213 · Cited by 49
CD2AP/SHIP1 Complex Positively Regulates Plasmacytoid Dendritic Cell Receptor Signaling by Inhibiting the E3 Ubiquitin Ligase Cbl
Bao, M., Hanabuchi, S., Facchinetti, V., Du, Q., Bover, L., Plumas, J., Chaperot, L., Cao, W., Qin, J., Sun, S.-C., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200887 · Cited by 49
Apoprotein E isoform-dependent expression and secretion of pro-inflammatory cytokines TNF-α and IL-6 in macrophages
Tsoi, L.-M., Wong, K., Liu, Y.-M., & Ho, Y.-Y. (2007) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2007.01.019 · Cited by 46
COG1410, a novel apolipoprotein‐E mimetic, improves functional and morphological recovery in a rat model of focal brain ischemia
Tukhovskaya, E. A., Yukin, A. Y., Khokhlova, O. N., Murashev, A. N., & Vitek, M. P. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21874 · Cited by 44
Alzheimer's disease is associated with low density of the long CR1 isoform
Mahmoudi, R., Kisserli, A., Novella, J., Donvito, B., Dramé, M., Réveil, B., Duret, V., Jolly, D., Pham, B., & Cohen, J. H. M. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.01.006 · Cited by 42
Phagocytosis and Cytokinesis: Do Cells Use Common Tools to Cut and to Eat? Highlights on Common Themes and Differences
Deschamps, C., Échard, A., & Niedergang, F. (2013) · Traffic · doi:10.1111/tra.12045 · Cited by 41
Human-Specific Evolutionary Changes in the Biology of Siglecs
Schwarz, F., Fong, J. J., & Varki, A. P. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-11280-0_1 · Cited by 41
Lack of apolipoprotein-E exacerbates experimental allergic encephalomyelitis
Karussis, D. M., Michaelson, D. M., Grigoriadis, N., Korezyn, A. D., Mizrachi-Koll, R., Chapman, S., Abramsky, O., & Chapman, J. (2003) · Multiple Sclerosis Journal · doi:10.1191/1352458503ms950oa · Cited by 36
The Inositol Phosphatase SHIP-1 Inhibits NOD2-Induced NF-κB Activation by Disturbing the Interaction of XIAP with RIP2
Condé, C., Rambout, X., Lebrun, M., Lecat, A., Di Valentin, E., Dequiedt, F., Piette, J., Gloire, G., & Legrand, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041005 · Cited by 33
Amyloid metabolism and secretases in Alzheimer’s disease
Xia, W. (2001) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-001-0101-z · Cited by 27
Complement receptor 1 coding variant p.Ser1610Thr in Alzheimer's disease and related endophenotypes
Cauwenberghe, C. V., Bettens, K., Engelborghs, S., Vandenbulcke, M., Dongen, J. V., Vermeulen, S., Vandenberghe, R. R., Deyn, P. P. D., Broeckhoven, C. V., & Sleegers, K. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.03.008 · Cited by 26
A survey of TREM2 antibodies reveals neuronal but not microglial staining in formalin-fixed paraffin-embedded postmortem Alzheimer's brain tissues
Satoh, J., Kawana, N., Yamamoto, Y., Ishida, T., Saito, Y., & Arima, K. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt184 · Cited by 21
Metabolism of Presenilins<
Thinakaran, G. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:17:2:183 · Cited by 16
Time for Reassessment
Starey, C. J. H. (1966) · BMJ · doi:10.1136/bmj.2.5514.646-f · Cited by 14
A novel compound heterozygous mutation in the DAP12 gene in a patient with Nasu-Hakola disease
Kuroda, R., Satoh, J., Yamamura, T., Anezaki, T., Terada, T., Yamazaki, K., Obi, T., & Mizoguchi, K. (2006) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2006.09.019 · Cited by 13
Erratum to “Exploratory analysis of seven Alzheimer's disease genes: disease progression” [Neurobiol. Aging 34 (2013) 1310.e1–1310.e7]
Ruiz, A., Hernández, I., Rosende‐Roca, M., González‐Pérez, A., Rodríguez‐Noriega, E., Ramírez‐Lorca, R., Mauleón, A., Moreno‐Rey, C., Boswell, L., Tune, L. E., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.06.016 · Cited by 5
Untitled work
Daws (2001) · doi:10.1002/1521-4141(200103)31:3
Untitled work
Webster (1996) · doi:10.1002/(sici)1097-4547(19961001)46:1

Research works printed but not linked: 6

Guerreiro R, Hardy J. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369:1569–70.
Bird TD. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369:1568.
Rajagopalan P, Hibar DP, Thompson PM. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369:1565–7.
Bertram L, Parrado AR, Tanzi RE. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369:1565.
Jonsson T, Stefansson K. TREM2 and neurodegenerative disease. N Engl J Med. 2013;369:1568–9.
Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, et al. TREM2 variants in Alzheimer’s disease. N Engl J Med. 2013;368:117–27. · DOI · Paper page

Sorted by citations

Microglia in physiology and disease
Wolf, S. A., Boddeke, H. W. G. M., & Kettenmann, H. (2017) · Annual Review of Physiology · doi:10.1146/annurev-physiol-022516-034406 · Cited by 1,426
Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
Guo, T., Zhang, D., Zeng, Y., Huang, T. Y., Xu, H., & Zhao, Y. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00391-7 · Cited by 994
New insights into the role of TREM2 in Alzheimer’s disease
Gratuze, M., Leyns, C. E. G., & Holtzman, D. M. (2018) · Molecular Neurodegeneration · doi:10.1186/s13024-018-0298-9 · Cited by 489
The role of astrocytes in amyloid production and Alzheimer's disease
Frost, G. R., & Li, Y. (2017) · Open Biology · doi:10.1098/rsob.170228 · Cited by 448
TREM2 in Neurodegenerative Diseases
Jay, T. R., von Saucken, V. E., & Landreth, G. E. (2017) · Molecular Neurodegeneration · doi:10.1186/s13024-017-0197-5 · Cited by 427

See all 161

Authors: Malik, M., Parikh, I., Vasquez, J. B., Smith, C., Tai, L., Bu, G., LaDu, M. J., Fardo, D. W., Rebeck, G. W., & Estus, S.
Affiliations: University of Kentucky (US)
University of Illinois Chicago (US)
Mayo Clinic (US)
Georgetown University Medical Center (US)
Corresponding author: Estus, Steven
ORCID: Malik, Manasi
Parikh, Ishita
Smith, Conor
Tai, Leon
Bu, Guojun
LaDu, Mary Jo
Fardo, David W.
Rebeck, G. William
Estus, Steven
Venue: Molecular Neurodegeneration
Publisher: Springer Science and Business Media LLC
Published: 2015-10-05
Volume: 10
Issue: 1
Pages: 52-52
ISSN: 1750-1326 (ISSN-L)
DOI: 10.1186/s13024-015-0048-1
PMC: PMC4595327
OpenAlex: W2119581346
Cited by: 161
References: 151
Citations by year: 2026: 6 · 2025: 14 · 2024: 11 · 2023: 19 · 2022: 16 · 2021: 18 · 2020: 21 · 2019: 15 · 2018: 12 · 2017: 18 · 2016: 10 · 2015: 1
FWCI: 1.09
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0/ (tdm)
creativecommons.org/licenses/by/4.0/ (vor)
Locations: Molecular Neurodegeneration (publishedVersion, cc-by)
Europe PMC (PubMed Central) (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
Rare & Special e-Zone (The Hong Kong University of Science and Technology) (submittedVersion)
UKnowledge (University of Kentucky) (submittedVersion, cc-by)
Funders: National Institute on Aging (R01AG045775, K25AG043546, P01AG030128, R21AG048498, R21 AG044682, R21AG051233)
BrightFocus Foundation (A2014210S)
Topics: Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords: Alzheimer's disease, microglial inflammation, genetic risk factors, TREM2, CD33, complement receptor 1, ABCA7, SHIP1, apolipoprotein E, microglial function, neuroinflammation, pathogenesis
MeSH terms: Alzheimer Disease, Animals, Humans, Inflammation, Risk Factors, Microglia, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Genetics ignite focus on microglial inflammation in Alzheimer’s disease

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks